BALL Score for Relapsed/Refractory CLL
ورودیهای بالینی بیمار
حداقل ۰.۱ — حداکثر ۵۰ • واحد: mg/dL
حداقل ۳ — حداکثر ۲۰ • واحد: g/dL
حداقل ۵۰ — حداکثر ۵۰۰۰ • واحد: U/L
حداقل ۱۰۰ — حداکثر ۵۰۰ • واحد: U/L
حداقل ۰ — حداکثر ۶۰۰ • واحد: months
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Risk0–1
- Intermediate Risk2–3
- High Risk4–4
The BALL Score for Relapsed/Refractory CLL calculates assessing prognosis of patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL) on targeted therapies. Key inputs include beta2 microglobulin. Scores guide initiating targeted anticoagulation therapy, platelet monitoring, or hematology specialist referral. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Assesses prognosis of patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL) on targeted therapies. The BALL Score (β2-microglobulin, Anemia, LDH, Last Therapy) helps estimate survival outcomes in patients with R/R-CLL who require further treatment with targeted therapies.
Clinical Indication
The BALL Score for Relapsed/Refractory CLL is indicated for bedside clinical practice to support Assesses prognosis of patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL) on targeted therapies. The BALL Score (β2-microglobulin, Anemia, LDH, Last Therapy) helps estimate survival outcomes in patients with R/R-CLL who require further treatment with targeted therapies.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with coagulopathy, thrombocytopenia, venous thromboembolism (DVT/PE), or hematologic neoplasms. Clinical application is indicated across Hematology-oncology services, bone marrow transplant units, anticoagulation clinics, and acute medical wards.
Limitations & Contraindications
Severe thrombocytopenia with concomitant microvascular thrombosis (TTP, HIT, DIC) represents a medical emergency requiring rapid intervention.
Clinical Pearls & Action Plan
Detailed history of heparin exposure, platelet count kinetics, and comprehensive coagulation profiles are vital in consumptive coagulopathies.
BALL Score = β2-microglobulin points + Anemia points + LDH points + Last therapy points
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| beta2_microglobulin | float | Yes | Beta-2-microglobulin level(mg/dL) |
| hemoglobin | float | Yes | Hemoglobin level(g/dL) |
| sex | string | Yes | Patient's biological sex |
| ldh | float | Yes | Lactate dehydrogenase (LDH) level(U/L) |
| ldh_upper_limit | float | Yes | Upper limit of normal for LDH (lab-specific)(U/L) |
| months_since_last_therapy | integer | Yes | Months since initiation of last therapy(months) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–1 | Low Risk | Low risk group |
| 2–3 | Intermediate Risk | Intermediate risk group |
| 4–4 | High Risk | High risk group |
Evidence-Based References (EBM)
- Soumerai JD, Ni A, Xing G, Huang J, Furman RR, Jones J, et al. Evaluation of the CLL-IPI in relapsed and refractory chronic lymphocytic leukemia in idelalisib phase-3 trials. Leuk Lymphoma. 2019 Jun;60(6):1438-1446. doi: 10.1080/10428194.2018.1540782.DOI: 10.1080/10428194.2018.1540782
- Soumerai JD, Ni A, Darif M, Londhe A, Xing G, Mun Y, et al. Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validations. Lancet Haematol. 2019 Jul;6(7):e366-e374. doi: 10.1016/S2352-3026(19)30085-7.DOI: 10.1016/S2352-3026(19)30085-7
- Gentile M, Morabito F, Del Poeta G, Mauro FR, Reda G, Sportoletti P, et al. Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study. Leukemia. 2021 Jan;35(1):235-238. doi: 10.1038/s41375-020-0816-y.DOI: 10.1038/s41375-020-0816-y
Related calculators
- International Prognostic Score for Asymptomatic Early-stage CLL (IPS-E)
- EUTOS Score for Chronic Myelogenous Leukemia (CML)
- Binet Staging System for Chronic Lymphocytic Leukemia (CLL)
- International Prognostic Index for Chronic Lymphocytic Leukemia (CLL-IPI)
- International Prognostic Index for Diffuse Large B-cell Lymphoma (IPI and R-IPI)